Veracyte | VCYT - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Agenus USD 16.02M 2.85M 2025-12
Agilent USD 25M 0 2026-03
Anika Therapeutics 179.39M 556.84M 2026-03
Arrowhead Research USD 22.5M 811K 2025-12
Bruker USD 8.1M 11.9M 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Illumina USD 26M 1000K 2025-12
Intrexon USD 2K 5K 2024-06
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Laboratory Of America USD 55.1M 100K 2026-03
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Siemens EUR 435M 1000K 2025-12
Sonic Healthcare AUD 86.91M 43.94M 2024-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Veracyte USD 2K 1000 2023-12
Waters USD 42M 33.38M 2026-03